Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial.
Increasing overall physical activity and aerobic fitness is associated with improvements in metabolic risk: cohort analysis of the ProActive trial.
复制标题
DOI:
10.1007/s00125-008-0949-4
复制
发表时间:
2008-05
期刊:
影响因子:
8.2
通讯作者:
Ekelund, U.
中科院分区:
文献类型:
--
作者:
Simmons, R. K.;Griffin, S. J.;Steele, R.;Wareham, N. J.;Ekelund, U.
Our aim was to examine the association between change in physical activity energy expenditure (PAEE), total body movement (counts per day) and aerobic fitness (maximum oxygen consumption []) over 1 year and metabolic risk among individuals with a family history of diabetes. Three hundred and sixty-five offspring of people with type 2 diabetes underwent measurement of energy expenditure (PAEE measured using the flex heart rate method), total body movement (daily activity counts from accelerometry data), predicted from a submaximal graded treadmill exercise test and anthropometric and metabolic status at baseline and 1 year (n = 321) in the ProActive trial. Clustered metabolic risk was calculated by summing standardised values for waist circumference, fasting triacylglycerol, insulin and glucose, blood pressure and the inverse of HDL-cholesterol. Linear regression was used to quantify the association between changes in PAEE, total body movement and fitness and clustered metabolic risk at follow-up. Participants increased their activity by 0.01 units PAEE kJ kg−1 day−1 over 1 year. Total body movement increased by an average of 9,848 counts per day. Change in total body movement (β = −0.066, p = 0.004) and fitness (β = −0.056, p = 0.003) was associated with clustered metabolic risk at follow-up, independently of age, sex, smoking status, socioeconomic status and baseline metabolic score. Small increases in activity and fitness were associated with a reduction in clustered metabolic risk in this cohort of carefully characterised at-risk individuals. Further research to quantify the reduction in risk of type 2 diabetes associated with feasible changes in these variables should inform preventive interventions. Clinical trial registration number: ISRCTN61323766.
登录
查看更多内容
影响因子:
4.5
作者:
Williams K;Prevost AT;Griffin S;Hardeman W;Hollingworth W;Spiegelhalter D;Sutton S;Ekelund U;Wareham N;Kinmonth AL
通讯作者:
Kinmonth AL
影响因子:
16.2
作者:
Ford, ES
通讯作者:
Ford, ES
DOI:
10.1249/01.mss.0000176466.78408.cc
发表时间:
2005-10-01
期刊:
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
影响因子:
--
作者:
Corder, K;Brage, S;Ekelund, U
通讯作者:
Ekelund, U
影响因子:
16.2
作者:
Ekelund, Ulf;Griffin, Simon J.;Wareham, Nicholas J.
通讯作者:
Wareham, Nicholas J.
影响因子:
16.2
作者:
Ekelund, U;Brage, S;Wareham, NJ
通讯作者:
Wareham, NJ